Free Republic 1st Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $74,463
91%  
Woo hoo!! And we're now over 91%!! Thank you everyone!! God bless.

Keyword: zmapp

Brevity: Headers | « Text »
  • Obama’s Ebola plans: A new boondoggle?

    11/12/2014 6:20:29 AM PST · by JustaCowgirl · 18 replies
    Fox News Politics ^ | Nov 12, 2014 | George Russell
    So far, the Administration has largely limited itself to providing a broad-brush sketch of the various areas where it intends to shower funds, including $4.64 billion for “immediate needs” and another $1.54 billion as a contingency “to ensure that there are resources available to respond to the evolving epidemic both domestically and internationally,” as the White House declared on November 5.
  • Ebola vaccine abandoned in 2008 after showing promise in trials

    10/21/2014 5:04:34 AM PDT · by Tolerance Sucks Rocks · 35 replies
    The Washington Times ^ | October 20, 2014 | Tom Howell, Jr.
    The pitch was intriguing: U.S. health officials wanted to fast-track trials for an Ebola vaccine and sounded the call for volunteers. Charles Sullivan called up the hotline on a whim, figuring the National Institutes of Health already had filled its queue and wouldn’t need him. But he was accepted for three rounds of shots of a deactivated virus, a year’s worth of blood analysis and a $900 check for his trouble. The clinical trial went well, and the vaccine seemed promising. A decade later, the country is still waiting for a vaccine amid a worldwide Ebola outbreak, and Mr. Sullivan...
  • Israeli Company Ready To Mass Produce Ebola Vaccine

    10/16/2014 8:21:26 AM PDT · by SeekAndFind · 67 replies
    Jewish Business News ^ | 10/16/2014 | Vered Weiss
    Israeli drug companies, such as Teva, are pretty good at producing imitation drugs quickly. Teva was truly disruptive to big pharma companies, since they often feared blockbuster drugs going off patent as Teva was ready and waiting with a quality generic imitation. It’s not so surprising that what is bad for big pharma is good for the patient and the consumer, and now an Israeli biotech company named Protalix is ready to replenish supplies of the experimental Ebola vaccine, ZMapp. The disease has already claimed the lives of 3,944, predominantly in Africa, but in the U.S., there has been one...
  • Obama Admin backing Ebola vaccines using aborted baby cell lines

    10/15/2014 4:02:10 PM PDT · by NYer · 33 replies
    Life Site News ^ | October 15, 2014 | John Henry Westen
    The Obama Administration has chosen to back Ebola vaccines made using cell lines cultivated from aborted babies, despite the fact that the government itself acknowledged that moral alternatives could also be used, according to a pro-life organization that specializes in advocating for morally produced vaccines.  Children of God for Life says it has discovered that several Ebola vaccines in development for use worldwide are being made using the aborted fetal cell lines.The proof of the use of the controversial cell lines in the manufacture of the vaccines is found in the patents. According to the patents, Glaxo SmithKline (GSK) and NIAID...
  • Faith, Medicine or ZMapp? What Cured The Ebola Patients?

    10/05/2014 4:58:05 PM PDT · by BunnySlippers · 67 replies
    NBC News ^ | 10/05/14
    The doctors who treated them have another idea and they think what they’ve learned can save Ebola patients in Africa. What almost killed Brantly, they say, were irregular heart rhythms caused by what’s called electrolyte imbalance — the loss of minerals because of his constant, unending diarrhea. “The closest infectious disease we can compare it to is cholera,” Dr. Bruce Ribner, who heads the special containment unit at Emory University Hospital in Atlanta where Writebol and Brantly were treated, told NBC News. As with cholera, the constant vomiting and diarrhea pull all the fluids from the body, and with them...
  • Ebola medicine in short supply (blame Republicans)

    10/03/2014 12:51:05 PM PDT · by redreno · 37 replies
    http://money.cnn.com ^ | 10/03/2014 | Cnn
    Making Ebola medicine Zmapp takes time and the company has already distributed what it has. Government budget cuts may be partially to blame for the shortage.
  • The US Is Scrambling To Produce The Experimental Ebola Drug ZMapp

    10/03/2014 4:33:05 AM PDT · by blam · 28 replies
    BI - The Telegraph (UK) ^ | 10-3-2014 | Philip Sherwell
    Philip Sherwell October 3, 2014 The US government is scrambling to start production of the experimental Ebola drug that is viewed as the most promising medical treatment in the fight against the virus. The ZMapp serum was used to treat two American missionaries who recovered from Ebola, but is not available for the Dallas man currently fighting the disease as the limited supplies made for clinical trials ran out in August. Federal officials and two of the world’s largest charities are in advanced talks with pharmaceutical companies to launch accelerated production from genetically-engineered tobacco plants and animal cells. But even...
  • DARPA May Have a Way to Stop Ebola in Its Tracks

    09/10/2014 3:49:02 PM PDT · by Qiviut · 23 replies
    New Republic ^ | September 9, 2014 | Brian Till
    Last week, as experts assembled at the World Health Organization headquarters in Geneva to discuss the Ebola outbreak in West Africa, there was a glaring absence in the public discourse: an accurate assessment of the U.S. government’s capacity to produce ZMapp, one of the experimental drugs under discussion for speeded approval. The drug, a cocktail of three monoclonal antibodies that has now been used in the treatment of at least seven Ebola patients, five of whom survived, has the potential to be an exceptional therapy against the virus. But the world’s supply is currently exhausted, and production of even several...
  • African demand for ZMapp Ebola drug grows as it completely heals monkeys in lab test

    08/30/2014 6:42:52 PM PDT · by SeekAndFind · 22 replies
    Monkeys infected with the Ebola virus survived after being treated with an experimental drug in a study that suggests the drug may be effective even after severe symptoms are present. Monkeys were given three doses of the antibody-based treatment ZMapp starting three to five days after being infected with a lethal dose of Ebola. All 18 monkeys treated with ZMapp survived, while three that were not given the medicine died, according to the results published in the journal Nature. "It is a really, really important study" as it is the longest researchers have waited after infecting monkeys with Ebola to...
  • WHO Worker contracts Ebola. Doctor who received ZMAPP Dies. Fatality Rate Increases to 70%.

    08/25/2014 6:54:15 PM PDT · by alexmark1917 · 20 replies
    For first time, a World Health Organization worker has fallen ill with Ebola http://www.cnn.com/2014/08/24/world/africa/ebola-outbreak/index.html An African doctor who received the experimental anti-Ebola drug ZMapp has died http://www.theverge.com/2014/8/25/6065417/african-doctor-who-was-treated-experimental-anti-ebola-drug-dead Doctor: Ebola Fatality Rate Running At 70 Percent -- Seven out of 10 patients admitted for Ebola die http://www.npr.org/2014/08/23/342652020/doctor-ebola-fatality-rate-running-at-70-percent?utm_content=buffer165fb&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer Exposed: Ebola Outbreak In Africa And The ‘Illuminati’ Connection http://www.osundefender.org/?p=183624 New hotbed of Ebola found in Congo as serum-treated doctor dies: http://rt.com/news/182708-ebola-mzapp-dies-congo/?utm_source=dlvr.it&utm_medium=twitter
  • ZMapp Ebola drug stock finished

    08/14/2014 9:09:31 AM PDT · by Smokin' Joe · 4 replies
    News 24 ^ | 8-12-14 | SAPA
    Washington - The supply of the experimental drug ZMapp used to treat people with the Ebola virus has been exhausted, the US company that makes the medication said on Monday. "We have complied with every request for ZMapp...
  • Ebola virus kills Spanish priest

    08/12/2014 4:35:18 AM PDT · by Covenantor · 13 replies
     Deutsche Welle ^ | 12.08.2014 | D-W staff
    Miguel Pajares, a Spanish priest who contracted the Ebola virus in Liberia, has died of the disease. He was the first European Ebola patient to be flown back to Europe for treatment. The 75-year-old Roman Catholic priest has died in a Madrid hospital, Spanish authorities confirmed on Tuesday. Pajares, who contracted the Ebola virus in Liberia - one of the hardest hit countries in the current outbreak - was airlifted from Liberia on August 7. He had been working for an NGO in the Liberian capital Monrovia. Pajares was one of only three people who have been treated with an...
  • Here's Everything We Know About The 'Secret Serum' Used To Treat An American With Ebola

    08/04/2014 1:08:30 PM PDT · by blam · 26 replies
    BI ^ | 8-4-2014 | Kevin Loria
    Kevin LoriaAugust. 4, 2014 Both of the Ebola-infected U.S. citizens in Liberia received a rare dose of what news reports called a "secret serum" to treat the virus before being transported to Emory University Hospital in Atlanta, according to a CNN report. And while some people do fight off the disease on their own, in the case of the two Americans, that experimental serum may have saved their lives. As Dr. Kent Brantly and missionary Nancy Writebol waited in a Liberian hospital, someone from the National Institutes of Health reached out to Samaritan's Purse, one of the two North Carolina-based...
  • Meet the Tiny Company Behind the Experimental Antibodies for Ebola

    08/05/2014 8:24:52 AM PDT · by SeekAndFind · 12 replies
    WPRO 630 ^ | 08/05/2014
    (SAN DIEGO) -- The companies manufacturing an experimental drug treating two American Ebola patients aren't among the largest multinational pharmaceuticals in the world. In fact, leading the effort is a small nine-employee firm in San Diego. Mapp Biopharmaceutical Inc., founded in 2003, says on its website that it develops, "novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense." Mapp's commercialization arm is LeafBio Inc., which has no employees and just two owners, Mapp President Larry Zeitlin tells ABC News. Mapp, along with LeafBio and Defyrus Inc. in Toronto, Canada, collaborated...
  • US government, military research program helped identify experimental Ebola treatment

    08/05/2014 7:05:15 AM PDT · by SeekAndFind · 13 replies
    Fox News ^ | 08/05/2014
    The experimental drug used to treat two American aid workers who have been infected with the Ebola virus has never been tested on humans before and was only identified earlier this year as part of an ongoing research program backed by the U.S. government and military. Dr. Kent Brantly and Nancy Writebol have each received doses of the drug, known as ZMapp, aimed at boosting the immune system's efforts to fight off Ebola and is made from antibodies produced by lab animals exposed to parts of the virus. The Associated Press reported that Writebol, 59, had received two doses of...